The Hidden Switch That Helps Breast Cancer Survive and Resist Treatment
A comprehensive new review maps how NF-κB signalling drives breast cancer progression, subtype-specific therapy resistance and tumour-microenvironment crosstalk, and argues ...
A comprehensive new review maps how NF-κB signalling drives breast cancer progression, subtype-specific therapy resistance and tumour-microenvironment crosstalk, and argues ...
UCLA oncologist Dr. Dennis Slamon has received the 2026 Albany Prize for discoveries that identified HER2-positive breast cancer and produced ...
A HER2-targeted mRNA lipid nanoparticle vaccine combined with fractionated radiotherapy suppressed tumor growth and reprogrammed the immune microenvironment in a ...
A Lithuanian case report describes a boy with novel compound heterozygous ERBB2 variants, only the second family ever documented with ...
A two-cohort study of 1,687 biliary tract cancer patients found that a prior breast cancer diagnosis was significantly more prevalent ...
A Vietnamese cohort study finds that the pleomorphic variant of invasive lobular carcinoma independently predicts axillary lymph node metastasis even ...
Researchers in Nanjing show that pretreatment contrast-enhanced ultrasound combined with molecular markers can predict whether breast tumors will shrink concentrically ...
An international expert consensus published in Clinical Cancer Bulletin establishes fifteen recommendations for molecular biomarker testing in intrahepatic cholangiocarcinoma, defining ...
New research shows that blocking the TREM2 receptor reprograms HER2-targeted CAR macrophages from suppressive to inflammatory, tumor-engulfing cells in breast ...
A single-cell atlas of 157,449 bladder cancer cells shows that antibody-drug conjugate targets rise and fall along a tumor differentiation ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine